Literature DB >> 24497198

Potential axillary nerve stretching during RSA implantation: an anatomical study.

Blandine Marion1, Franck Marie Leclère, Vincent Casoli, Federico Paganini, Frank Unglaub, Christian Spies, Philippe Valenti.   

Abstract

Clinical and subclinical neurological injury after reverse shoulder arthroplasty (RSA) may jeopardize functional outcomes due to the risk of irreversible damage to the axillary nerve. We proposed a simple anatomical study in order to assess the macroscopic effects on the axillary nerve when lowering the humerus as performed during RSA implantation. We also measured the effect on the axillary nerve of a lateralization of the humerus. Between 2011 and 2012, cadaveric dissections of 16 shoulder specimens from nine fresh human cadavers were performed in order to assess the effects on the axillary nerve after the lowering and lateralization of the humerus. We assessed the extent of stretching of the axillary nerve in four positions in the sagittal plane [lowering of the humerus: great tuberosity in contact with the acromion (position 1), in contact with the upper (position 2), middle (position 3) and lower rim of the glenoid (position 4)] and three positions in the frontal plane [lateralization of the humerus: humerus in contact with the glenoid (position 1), humerus lateralized 1 cm (position 2) and 2 cm (position 3)]. When the humerus was lowered, clear macroscopical changes appeared below the middle of the glenoid (the highest level of tension). As regards the lateralization of the humerus, macroscopic study and measurements confirm the absence of stretching of the nerve in those positions. Lowering of the humerus below the equator of the glenoid changes the course and tension of the axillary nerve and may lead to stretching and irreversible damage, compromising the function of the deltoid. Improvements in the design of the implants and modification of the positioning of the glenosphere to avoid notching and to increase mobility must take into account the anatomical changes induced by the prosthesis and its impact on the brachial plexus. Level of Evidence and study type Level IV.

Entities:  

Mesh:

Year:  2014        PMID: 24497198     DOI: 10.1007/s12565-014-0229-y

Source DB:  PubMed          Journal:  Anat Sci Int        ISSN: 1447-073X            Impact factor:   1.741


  6 in total

Review 1.  Management of painful reverse shoulder arthroplasty.

Authors:  Anders L Ekelund
Journal:  Shoulder Elbow       Date:  2017-04-09

Review 2.  Neurologic complications in primary anatomic and reverse total shoulder arthroplasty: A review.

Authors:  Sravya P Vajapey; Erik S Contreras; Gregory L Cvetanovich; Andrew S Neviaser
Journal:  J Clin Orthop Trauma       Date:  2021-06-09

3.  Complications in reverse shoulder arthroplasty.

Authors:  Raul Barco; Olga D Savvidou; John W Sperling; Joaquín Sanchez-Sotelo; Robert H Cofield
Journal:  EFORT Open Rev       Date:  2017-03-13

Review 4.  The modern reverse shoulder arthroplasty and an updated systematic review for each complication: part I.

Authors:  Sarav S Shah; Benjamin T Gaal; Alexander M Roche; Surena Namdari; Brian M Grawe; Macy Lawler; Stewart Dalton; Joseph J King; Joshua Helmkamp; Grant E Garrigues; Thomas W Wright; Bradley S Schoch; Kyle Flik; Randall J Otto; Richard Jones; Andrew Jawa; Peter McCann; Joseph Abboud; Gabe Horneff; Glen Ross; Richard Friedman; Eric T Ricchetti; Douglas Boardman; Robert Z Tashjian; Lawrence V Gulotta
Journal:  JSES Int       Date:  2020-09-07

Review 5.  Radiological changes, infections and neurological complications after reverse shoulder arthroplasty related to different design types and their rates: Part II.

Authors:  Marko Nabergoj; Patrick J Denard; Philippe Collin; Rihard Trebše; Alexandre Lädermann
Journal:  EFORT Open Rev       Date:  2021-11-19

Review 6.  The Evolution of Reverse Total Shoulder Arthroplasty-From the First Steps to Novel Implant Designs and Surgical Techniques.

Authors:  Julia K Frank; Paul Siegert; Fabian Plachel; Philipp R Heuberer; Stephanie Huber; Jakob E Schanda
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.